Barclays »

Avalyn Pharma shares owned by Barclays

Quarter-by-quarter ownership of Avalyn Pharma (AVLN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Avalyn Pharma

Tip: Access up to 7 years of quarterly data

All positions including Avalyn Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalyn Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $145k 4.4k 32.92

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Avalyn Pharma

FMR
Novo A/S
Sr One Capital Management
Perceptive Advisors
Suvretta Capital Management
NVP Associates
Wellington Management Company
Catalio Capital Management
Eventide Asset Management
Bellevue Group
BlackRock
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Andera Partners
Jennison Associates

View all funds holding Avalyn Pharma